DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
Inzucchi SE, Zinman B, Wanner C. et al.
SGLT-2 inhibitors and cardiovascular risk: proposed pathways and review of ongoing outcome trials.
Diab Vasc Dis Res 2015;
12: 90-100
We do not assume any responsibility for the contents of the web pages of other providers.